ICG
WST icon

InterOcean Capital Group’s West Pharmaceutical WST Stock Holding History

InterOcean Capital Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-587
Closed -$220K – 503
2023
Q3 		$220K Sell
587
-422
-42% -$163K 0.01% 396
2023
Q2 		$386K Sell
1,009
-681
-40% -$243K 0.01% 312
2023
Q1 		$586K Sell
1,690
-121
-7% -$35.4K 0.02% 239
2022
Q4 		$426K Buy
1,811
+54
+3% +$12.8K 0.02% 284
2022
Q3 		$432K Buy
1,757
+397
+29% +$121K 0.02% 258
2022
Q2 		$411K Buy
+1,360
New +$443K 0.02% 269

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

InterOcean Capital Group's WST Position: Q4 2023 in Review

InterOcean Capital Group sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 587 shares — an estimated $220K sold.

InterOcean Capital Group first reported a position in WST in Q2 2022 and held it in 6 quarters. The position peaked at $586K in Q1 2023. 783 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • InterOcean Capital Group reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • InterOcean Capital Group sold 587 West Pharmaceutical shares in Q4 2023, an estimated $220K.
  • InterOcean Capital Group first reported a position in West Pharmaceutical in Q2 2022 and held it in 6 quarters.
  • InterOcean Capital Group's West Pharmaceutical position peaked at $586K in Q1 2023.
  • 783 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on InterOcean Capital Group's 13F filing for Q4 2023, filed 9 Feb 2024.